Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADEFOVIR for Chronic hepatitis b: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 77 adverse event reports in the FDA FAERS database where ADEFOVIR was used for Chronic hepatitis b.

Most Reported Side Effects for ADEFOVIR

Side Effect Reports % Deaths Hosp.
Drug resistance 86 45.3% 2 3
Viral infection 29 15.3% 2 0
Genotype drug resistance test 27 14.2% 0 0
Pathogen resistance 18 9.5% 2 0
Viral mutation identified 17 9.0% 2 0
Osteomalacia 14 7.4% 0 8
Treatment failure 14 7.4% 0 0
Virologic failure 13 6.8% 0 0
Hepatitis b dna increased 12 6.3% 2 0
Hepatocellular carcinoma 10 5.3% 3 1
Alanine aminotransferase increased 9 4.7% 0 0
Condition aggravated 9 4.7% 4 7
Drug ineffective 9 4.7% 1 1
Hypophosphataemia 9 4.7% 0 5
Pain 8 4.2% 0 5

Other Indications for ADEFOVIR

Hepatitis b (37) Hepatic cirrhosis (11) Hiv infection (11) Product used for unknown indication (11)

Other Drugs Used for Chronic hepatitis b

TENOFOVIR DISOPROXIL (1,156) LAMIVUDINE (998) ADEFOVIR DIPIVOXIL (776) ENTECAVIR (705) TENOFOVIR ALAFENAMIDE (679) PEGINTERFERON ALFA-2A (234) TENOFOVIR (187) TELBIVUDINE (153) EMTRICITABINE\TENOFOVIR DISOPROXIL (34) PEGINTERFERON ALFA-2B (32)

Related Pages

ADEFOVIR Full Profile All Chronic hepatitis b Drugs ADEFOVIR Demographics ADEFOVIR Timeline